engineering modulates immune effector functions, while phage display and humanization techniques accelerate antibody development.Immune checkpoint inhibitors have transformed cancer therapy. Protein engineering and…
action, clinical applications, advantages, and limitations. Additionally, it explores recent advancements such as immune checkpoint inhibitors, CAR-T cell therapy, monoclonal antibodies, and cancer vaccines. The review…
Immune checkpoint inhibitors (ICIs) offer promise in ovarian cancer by reactivating anti-tumor immunity, but the immunosuppressive tumor microenvironment poses a challenge for durable efficacy. Combination strategies…
discuss unique repair processes for oxidative and mitochondrial DNA damage, and examine DNA damage checkpoints. The interplay with CRISPR-Cas gene editing is also covered. This body of work underscores
Immunotherapy, especially immune checkpoint inhibitors (ICIs), is rapidly transforming gynecologic oncology, demonstrating efficacy in advanced ovarian, cervical, and endometrial cancers. Pembrolizumab has become a…
conventional neoadjuvant chemotherapy has posed challenges in treatment optimization.. The emergence of immune checkpoint inhibitors has revolutionized the management of DMMR metastatic colorectal cancer, prompting…
fosters progression and drug resistance. The role of epigenetic alterations and mechanisms of immune checkpoint blockade resistance are discussed. Novel approaches like liquid biopsy, RNA-based therapies, CRISPR/Cas9…
fundamental process tightly regulated by intricate mechanisms, including cyclins, Cyclin-Dependent Kinases, checkpoints, and post-translational modifications. Dysregulation of this control, often influenced by factors…
stem cells, cytokine therapy, donor lymphocyte infusion, gene-modified T cells, gut microbiome manipulation, checkpoint inhibitors, induced pluripotent stem cells, and regulatory T cells. The goal is to refine HSCT
targeted therapies, focusing on molecular pathways such as PI3K/AKT/mTOR and immune checkpoint inhibitors. We review clinical trial data, discuss treatment efficacy, and highlight future directions. Results indicate…
resistance and toxicity have driven the development of novel approaches. Immunotherapy, particularly immune checkpoint inhibitors, has shown promise in improving survival outcomes for patients with advanced bladder…
have led to the development of targeted immunomodulatory agents such as cytokine inhibitors, immune checkpoint regulators, and small-molecule modulators. These innovations have revolutionized therapeutic approaches…
Retrospective and prospective studies involving advanced-stage HCC patients support combining SBRT with immune checkpoint inhibitors. This review aims to discuss the mechanisms by which immunotherapy can improve the…
chronic cholestasis and loss of intrahepatic bile ducts. VBDS has been reported also following checkpoint inhibitor treatment. We compared CD3+, CD4+, CD8+, CD20+, CD56+, PD-1+ and PD-L1+ lymphocyte ... primary human…
types, current clinical applications, and the challenges associated with its use. Recent advances, including checkpoint inhibitors, CAR T cell therapy, and personalized immunotherapies, highlight the growing potential…
cancers such as melanoma, lung or renal cancer has dramatically changed since Immune Checkpoint Inhibitors (ICIs) including anti-PD-1, anti-PD-L1 and anti CTLA-4 therapies developed. However
target these pathways, such as toll-like receptor (TLR) agonists, cytokine therapies, and immune checkpoint inhibitors, aiming to boost DC activation and antigen presentation. The results from preclinical and clinical
diseases. This article explores cutting-edge innovations in immune system therapies, including immune checkpoint inhibitors, CAR-T cell therapies, immune modulation via biologics, and personalized immunotherapy. The…
immune system to target and eliminate cancer cells. Key components such as immune checkpoint inhibitors, ‘CAR-T cell therapy’, monoclonal antibodies, and cancer vaccines play a crucial role. The study
focusing on innovative approaches such as CAR-T cell therapy, bispecific antibodies, and immune checkpoint inhibitors. Additionally, it examines the integration of advanced technologies like artificial intelligence and…
ability to target and eliminate tumor cells. We explore key pharmacological agents, including checkpoint inhibitors, immune modulators, and targeted therapies, and their mechanisms of action. Additionally, the article…
pharmacokinetic interactions associated with contemporary anticancer therapies, including small molecules, monoclonal antibodies, and immune checkpoint inhibitors. We examine how these interactions can alter drug…
encompasses various strategies aimed at altering the immune system’s response to cancer, including checkpoint inhibitors, cancer vaccines, and adoptive cell therapies. These approaches leverage the body’s own immune
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.